Koppel Adam
SEC CIK 1578965 · EDGAR
BoughtSold
Most active insiders at KLRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kaplan Andrew T. | Dir, 10% | $134.38M | — |
| 2 | BAIN CAPITAL INVESTORS LLC | 10% | $134.38M | — |
| 3 | Bain Capital Life Sciences Investors, LLC | 10% | $25.00M | — |
| 4 | Koppel Adam | Dir, 10% | $25.00M | — |
| 5 | RTW INVESTMENTS, LP | 10% | $8.00M | — |
| 6 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% | — | — |
| 7 | Renaud Ronald C JR | CEO, Pres, Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-04-20 18:08 | 2026-04-20 | KLRA | Kailera Therapeutics, Inc. | Koppel Adam | Dir, 10% | C - Cnv Deriv | — | +21.02M | 21.02M | New | — |
| DI | 2026-04-20 18:08 | 2026-04-20 | KLRA | Kailera Therapeutics, Inc. | Koppel Adam | Dir, 10% | P - Purchase | $16.00 | +1.56M | 22.58M | +7% | +$25.00M |
| I | 2024-01-12 | 2024-01-11 | SLDB | Solid Biosciences Inc. | Koppel Adam | Dir, 10% | A - Grant | $5.53 | +904.2K | 4.03M | +29% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations